Health Condition 1: N461- Oligospermia
Conditions
Interventions
Intervention1: Speman GNX tablet: 1 tablet twice daily
Control Intervention1: Placebo: One tablet twice daily
Sponsors
The Himalaya Drug Company
Eligibility
Inclusion criteria
Inclusion criteria: 1.Healthy males 21-45 years of age with infertility for more than 3 months, diagnosed with Oligospermia (Defined by 2.No past history of renal, hepatic or any other chronic illness in the past 3.Normal liver and renal functions tests 4.Patients freely willing and able to provide written informed consent, willing to follow study procedures
Exclusion criteria
Exclusion criteria: -Complete azoospermia in pre-treatment samples -Any congenital anomaly resulting in oligospermia -Evidence of male accessory gland infection, -Any recent medical or surgical illness, -Hormone/ any other treatment for promoting fertility in the last three months. -The patients with undescended testis, evidence of thyroid diseases, inguinal hernia, moderate to moderate to severe diabetes with complications and other systemic diseases requiring specific therapies will be excluded from the study. -Not willing to provide the informed consent form
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Improve in the sperm count to normal level. 2.Improvement sperm quality, sperm morphology and sperm motility, liquidation, semen volume and sperm density value Timepoint: 1.Improve in the sperm count to normal level. 2.Improvement sperm quality, sperm morphology and sperm motility, liquidation, semen volume and sperm density value | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Incidence of adverse events during the study period. 2.Number of conceptions measured in the course of clinical trial.Timepoint: Visit 0- Screening Visit Visit 1- At entry visit Visit 2- At the end of day 30 Visit 3- At the end of day 60 Visit 4- (End of the treatment) At the end of day 90 | — |
Countries
India
Contacts
Public ContactDr Palaniyamma
Pearl Health Care
Outcome results
None listed